Over the last 7 days, the United States market has risen 5.2%, contributing to a 9.9% increase over the past year, with earnings forecasted to grow by 14% annually. In this environment of growth, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est) MINISO Group Holding (NYSE:MNSO) $17.60 $34.83 49.5% Lantheus Holdings (NasdaqGM:LNTH) $103.96 $203.99 49% Trade Desk (NasdaqGM:TTD) $54.67 $106.35 48.6% SharkNinja (NYSE:SN) $81.41 $160.42 49.3% Curbline Properties (NYSE:CURB) $22.89 $45.04 49.2% CBIZ (NYSE:CBZ) $67.22 $133.31 49.6% Ligand Pharmaceuticals (NasdaqGM:LGND) $111.38 $220.47 49.5% StoneCo (NasdaqGS:STNE) $14.08 $27.73 49.2% BigCommerce Holdings (NasdaqGM:BIGC) $5.29 $10.31 48.7% Roku (NasdaqGS:ROKU) $69.28 $135.72 49%

Click here to see the full list of 185 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

GeneDx Holdings

Overview: GeneDx Holdings Corp. is a genomics company that offers genetic testing services and has a market cap of approximately $3.21 billion.

Operations: The company generates revenue through its Gene Dx segment, contributing $302.29 million, and its Legacy Sema4 segment, which adds $3.16 million.

Estimated Discount To Fair Value: 14.8%

GeneDx Holdings is trading at US$116.97, 14.8% below its estimated fair value of US$137.35, indicating potential undervaluation based on cash flows. The company reported a revenue increase to US$305.45 million in 2024, with expected growth driven by strategic expansions into areas like Inborn Errors of Immunity and cerebral palsy testing. Despite recent share price volatility, GeneDx's focus on genetic insights and patient care could enhance future profitability and revenue growth prospects in the healthcare sector.

The growth report we've compiled suggests that GeneDx Holdings' future prospects could be on the up. Click here to discover the nuances of GeneDx Holdings with our detailed financial health report.NasdaqGS:WGS Discounted Cash Flow as at Apr 2025

Dayforce

Overview: Dayforce Inc. is a human capital management software company operating in the United States, Canada, Australia, and internationally, with a market cap of approximately $9.06 billion.

Operations: The company generates revenue of $1.76 billion from its Human Capital Management (HCM) segment.

Estimated Discount To Fair Value: 31.4%

Dayforce, trading at US$57.35, is 31.4% below its estimated fair value of US$83.57, suggesting it may be undervalued based on cash flows. Despite a decline in profit margins from 3.6% to 1%, revenue grew to US$1.76 billion in 2024 and is forecasted to outpace the broader U.S. market growth rate with a projected annual earnings increase of 36.3%. Recent partnerships and strategic financial adjustments could support future valuation improvements.

Story Continues

Our expertly prepared growth report on Dayforce implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of Dayforce.NYSE:DAY Discounted Cash Flow as at Apr 2025

SharkNinja

Overview: SharkNinja, Inc. is a product design and technology company that offers consumer solutions in the United States, China, and internationally with a market cap of $11.24 billion.

Operations: The company generates revenue from its Appliance & Tool segment, amounting to $5.53 billion.

Estimated Discount To Fair Value: 49.3%

SharkNinja, trading at US$81.41, is significantly undervalued based on cash flows with an estimated fair value of US$160.42. Recent earnings grew by 162.6%, and future earnings are projected to grow faster than the U.S. market at 16.8% annually, supported by innovative product launches like FlexBreeze™ and strategic leadership changes aimed at enhancing consumer engagement and global growth strategies under new CGO Michelle Crossan-Matos.

Upon reviewing our latest growth report, SharkNinja's projected financial performance appears quite optimistic. Dive into the specifics of SharkNinja here with our thorough financial health report.NYSE:SN Discounted Cash Flow as at Apr 2025

Key Takeaways

Explore the 185 names from our Undervalued US Stocks Based On Cash Flows screener here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready For A Different Approach?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:WGSNYSE:DAY and NYSE:SN.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]